3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Terminated
1
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Lung Neoplasms
4
Ovarian Neoplasms
2
Neoplasms
2
Urinary Bladder Neoplasms
1
Tuberculosis, Pulmonary
1
Thoracic Diseases
1
Sedation
1
Recurrence
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Intraoral Tumor
1
Hypoxia
1
Esophageal Neoplasms
1
Emergence Delirium
1
Disease Progression
1
Delirium
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Breast Neoplasms
1
Brain Neoplasms
1
Interventions
pembrolizumab
117
Carboplatin
104
Pemetrexed
93
Cisplatin
59
Paclitaxel
49
Drug Therapy
41
osimertinib
40
Nivolumab
40
Docetaxel
37
Specimen Handling
33
Magnetic Resonance Spectroscopy
28
Bevacizumab
26
durvalumab
22
Gemcitabine
22
cemiplimab
21
130-nm albumin-bound paclitaxel
21
Radiotherapy
20
tislelizumab
19
Radiosurgery
19
atezolizumab
17
aflutinib
15
Immunotherapy
15
Cetuximab
15
Platinum Compounds
13
Ipilimumab
13
Immune Checkpoint Inhibitors
13
Biopsy
12
Standard of Care
11
Surgical Procedures, Operative
10
Injections
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Non-Small-Cell Lung
×
Propofol
×
Clear all
NCT06330038
2026-04-20
GASTIVA
Samsung Medical Center
Phase 4
Recruiting
5,384 enrolled